BIONICHE ANIMAL HEALTH CANADA INC - نتائج البحث

تايوان - الصينية - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

斯莫克必恩易福中心靜脈輸注液

台灣費森尤斯卡比股份有限公司臺北市大安區仁愛路3段30號5樓、32號5樓 (12980985) - triglycerides medium chain;;soybean oil ( eq to soya bean oil);;fish-oil rich in omega-3 acids;;olive oil;;l-valine;;l-threonine;;l-lysine acetate;;glycine (eq to aminoacetic acid)(eq to glycocoll);;l-tryptophan;;l-phenylalanine;;l-histidine;;l-serine;;taurine (eq to aminoethyl sulfonic acid );;l-methionine;;l-leucine;;l-proline;;l-tyrosine;;l-isoleucine;;l-alanine;;l-arginine;;glucose monohydrate - 注射劑 - l-alanine (4020100202) mg; l-arginine (4020100305) mg; l-histidine (4020100902) mg; l-isoleucine (4020101002) mg; l-leucine (4020101202) mg; l-lysine acetate (4020101322) corresponding to l-lysine 6.6mgmg; l-methionine (4020101502) mg; l-phenylalanine (4020101702) mg; l-proline (4020101802) mg; l-serine (4020101902) mg; l-threonine (4020102002) mg; l-tryptophan (4020102102) mg; l-tyrosine (4020102202) mg; l-valine (4020102302) mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) mg; taurine (eq to aminoethyl sulfonic acid ) (9200000920) mg; glucose monohydrate (4020000760) corresponding to glucose (anhydrous) 420mgmg; soybean oil ( eq to soya bean oil) (4020001600) soya-bean oil, refinedmg; fish-oil rich in omega-3 acids (4020003620) mg; triglycerides medium chain (5640001102) mg; olive oil (9600021200) olive oil, refinedmg - combinations - 無法給予口服/腸道營養或口服/腸道營養不足或禁用時，適用於成人及2歲以上兒童病患的靜脈營養劑。

تايوان - الصينية - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

因特立滋10%注射液

臺灣費森尤斯卡比股份有限公司臺北市大安區仁愛路3段30號5樓、32號5樓 (12980985) - soybean oil ( eq to soya bean oil) - 注射劑 - soybean oil ( eq to soya bean oil) (4020001600) mg - fat emulsions - 病患手術前後營養之補給。

تايوان - الصينية - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

因特立滋20%注射液

臺灣費森尤斯卡比股份有限公司臺北市大安區仁愛路3段30號5樓、32號5樓 (12980985) - soybean oil ( eq to soya bean oil) - 注射劑 - soybean oil ( eq to soya bean oil) (4020001600) (fract) 200mg - fat emulsions - 手術前後、胃腸疾患、慢性疾患之營養補給

تايوان - الصينية - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

安敏若優周邊靜脈輸注液

台灣費森尤斯卡比股份有限公司臺北市大安區仁愛路3段30號5樓、32號5樓 (12980985) - l-phenylalanine;;l-leucine;;glycine (eq to aminoacetic acid)(eq to glycocoll);;l-alanine;;l-proline;;l-valine;;l-tryptophan;;calcium chloride dihydrate;;l-tyrosine;;l-isoleucine;;glucose monohydrate;;magnesium sulphate heptahydrate ;;sodium glycerophosphate hydrated;;l-arginine;;l-lysine acetate;;taurine (eq to 2-aminoethane sulfonic acid);;sodium acetate (trihydrate);;l-methionine;;l-histidine;;l-threonine;;potassium chloride;;l-serine - 注射液劑 - sodium acetate (trihydrate) (4008007670) (eq. to sodium acetate......0.70 g)gm; calcium chloride dihydrate (4012000350) (eq. to calcium chloride......0.18 g)gm; potassium chloride (4012001800) gm; glucose monohydrate (4020000760) (eq. to glucose anhydrous......63.0 g)gm; l-alanine (4020100202) gm; l-arginine (4020100302) gm; l-histidine (4020100902) gm; l-isoleucine (4020101002) gm; l-leucine (4020101202) gm; l-lysine acetate (4020101322) (eq. to lysine......2.31 g)gm; l-methionine (4020101502) gm; l-phenylalanine (4020101702) gm; l-proline (4020101802) gm; l-serine (4020101902) gm; l-threonine (4020102002) gm; l-tryptophan (4020102102) gm; l-tyrosine (4020102202) gm; l-valine (4020102302) gm; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) gm; magnesium sulphate heptahydrate (5612001583) (eq. to magnesium sulphate......0.38 g)gm; taurine (eq to 2-aminoethane sulfonic acid) (9200000900) gm; sodium glycerophosphate hydrated (9200008510) (eq. to sodium glycerophosphate (anhydrous))gm - combinations - 靜脈營養輸注，適用於無法或禁止由口腔進食或經腸道獲取足夠胺基酸、電解質及葡萄糖營養之成年病人。

تايوان - الصينية - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

喜開悅150 mg/ml注射劑

瑞士商艾伯維藥品有限公司台灣分公司台北市中山區民生東路三段49號及51號15樓 (53653958) - risankizumab - 注射液劑 - risankizumab (1013007300) mg - risankizumab - 1. 乾癬：適合接受全身性治療的中度至重度斑塊性乾癬成人病人。 2. 乾癬性關節炎：單獨使用或與傳統疾病緩解型抗風濕藥物(cdmard)合併使用，適用於治療對疾病緩解型抗風濕藥物(dmards)療效不佳或無法耐受之活動性乾癬性關節炎成人病人。 3. 適用於治療16歲以上之中度至重度克隆氏症：對傳統治療或生物製劑治療反應不佳、失去反應、無法耐受、或不適合接受上述治療之病人。 4.掌蹠膿皰症：適用於治療對傳統療法未能產生有效反應或無法耐受的中度至重度掌蹠膿皰症成人病人。